Matinas Biopharma Holdings, Inc. (MTNB) — 10-Q Filings
All 10-Q filings from Matinas Biopharma Holdings, Inc.. Browse 6 Quarterly Report reports with AI-powered summaries and risk analysis.
10-Q Filings (6)
-
Matinas BioPharma Narrows Losses, Faces Going Concern Doubt
— Nov 10, 2025 Risk: high
Matinas BioPharma Holdings, Inc. (MTNB) reported a net loss of $1.53 million for the three months ended September 30, 2025, a significant improvement from the $ -
Matinas BioPharma Narrows Losses, Faces Going Concern Doubt
— Aug 14, 2025 Risk: high
Matinas BioPharma Holdings, Inc. reported a net loss of $6.901 million for the six months ended June 30, 2025, a significant improvement from the $11.543 millio -
Matinas BioPharma Files Q1 2025 10-Q
— May 15, 2025 Risk: medium
Matinas BioPharma Holdings, Inc. filed its 10-Q for the period ending March 31, 2025. The filing details financial performance and operational updates for the f -
Matinas BioPharma Files Q3 2024 10-Q Report
— Nov 13, 2024 Risk: medium
Matinas BioPharma Holdings, Inc. filed its Q3 10-Q report on November 13, 2024, for the period ending September 30, 2024. The filing details financial performan -
Matinas BioPharma Files Q2 2024 10-Q
— Aug 14, 2024 Risk: medium
Matinas BioPharma Holdings, Inc. filed its 10-Q for the period ending June 30, 2024. The company reported financial results and provided updates on its business -
Matinas BioPharma Holdings, Inc. Files 10-Q for Period Ending March 31, 2024
— May 9, 2024 Risk: medium
Matinas BioPharma Holdings, Inc. (MTNB) filed a Quarterly Report (10-Q) with the SEC on May 9, 2024. Matinas BioPharma Holdings, Inc. filed a 10-Q report for th
Popular Companies
AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX